Rachel Morehouse

1.8k total citations
29 papers, 1.2k citations indexed

About

Rachel Morehouse is a scholar working on Experimental and Cognitive Psychology, Endocrine and Autonomic Systems and Psychiatry and Mental health. According to data from OpenAlex, Rachel Morehouse has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Experimental and Cognitive Psychology, 12 papers in Endocrine and Autonomic Systems and 8 papers in Psychiatry and Mental health. Recurrent topics in Rachel Morehouse's work include Circadian rhythm and melatonin (11 papers), Mental Health Research Topics (7 papers) and Sleep and related disorders (7 papers). Rachel Morehouse is often cited by papers focused on Circadian rhythm and melatonin (11 papers), Mental Health Research Topics (7 papers) and Sleep and related disorders (7 papers). Rachel Morehouse collaborates with scholars based in Canada, Australia and United States. Rachel Morehouse's co-authors include Raymond W. Lam, Anthony Levitt, Erin E. Michalak, Robert D. Levitan, Edwin M. Tam, Lakshmi N. Yatham, Murray W. Enns, Adam Moscovitch, Sidney H. Kennedy and Glenda MacQueen and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

Rachel Morehouse

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Morehouse Canada 16 484 441 341 205 174 29 1.2k
Ulrich Hemmeter Switzerland 18 312 0.6× 443 1.0× 509 1.5× 164 0.8× 161 0.9× 77 1.3k
Edda Pjrek Austria 16 509 1.1× 350 0.8× 186 0.5× 145 0.7× 97 0.6× 47 1.1k
Ho‐Kyoung Yoon South Korea 24 314 0.6× 427 1.0× 403 1.2× 248 1.2× 159 0.9× 68 1.5k
D. Pringuey France 13 336 0.7× 335 0.8× 315 0.9× 370 1.8× 121 0.7× 90 1.3k
Philippe Hubain Belgium 19 225 0.5× 511 1.2× 527 1.5× 209 1.0× 235 1.4× 54 1.3k
Andrés Magnússon Iceland 19 487 1.0× 346 0.8× 197 0.6× 350 1.7× 142 0.8× 25 1.6k
P. Schüssler Germany 25 647 1.3× 415 0.9× 422 1.2× 103 0.5× 316 1.8× 47 1.4k
Euridice Campori Italy 13 542 1.1× 589 1.3× 353 1.0× 456 2.2× 67 0.4× 16 1.3k
Norifumi Tsuno Japan 12 183 0.4× 675 1.5× 482 1.4× 195 1.0× 179 1.0× 20 1.3k
N E Rosenthal United States 19 848 1.8× 545 1.2× 285 0.8× 621 3.0× 195 1.1× 24 1.7k

Countries citing papers authored by Rachel Morehouse

Since Specialization
Citations

This map shows the geographic impact of Rachel Morehouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Morehouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Morehouse more than expected).

Fields of papers citing papers by Rachel Morehouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Morehouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Morehouse. The network helps show where Rachel Morehouse may publish in the future.

Co-authorship network of co-authors of Rachel Morehouse

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Morehouse. A scholar is included among the top collaborators of Rachel Morehouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Morehouse. Rachel Morehouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Emma, Erin E. Michalak, Edwin M. Tam, et al.. (2021). Functional outcomes with bright light in monotherapy and combined with fluoxetine in patients with major depressive disorder: Results from the LIFE-D trial. Journal of Affective Disorders. 297. 396–400. 1 indexed citations
2.
Morton, Emma, Erin E. Michalak, Anthony Levitt, et al.. (2020). Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial. The Canadian Journal of Psychiatry. 66(3). 289–297. 5 indexed citations
3.
Ravindran, Arun, Lynda G. Balneaves, Guy Faulkner, et al.. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. FOCUS The Journal of Lifelong Learning in Psychiatry. 16(1). 85–94. 22 indexed citations
4.
Levitan, Robert D., Anthony Levitt, Erin E. Michalak, et al.. (2018). Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression. The Journal of Clinical Psychiatry. 79(4). 5 indexed citations
5.
Cheung, Amy, Carolyn S. Dewa, Erin E. Michalak, et al.. (2012). Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine. Depression Research and Treatment. 2012. 1–5. 6 indexed citations
6.
Morehouse, Rachel, Glenda MacQueen, & Sidney H. Kennedy. (2011). Barriers to achieving treatment goals: A focus on sleep disturbance and sexual dysfunction. Journal of Affective Disorders. 132. S14–S20. 19 indexed citations
7.
Enns, Murray W., Brian J. Cox, Anthony Levitt, et al.. (2006). Personality and seasonal affective disorder: Results from the CAN-SAD study. Journal of Affective Disorders. 93(1-3). 35–42. 20 indexed citations
8.
Lam, Raymond W., Anthony Levitt, Robert D. Levitan, et al.. (2006). The Can-SAD Study: A Randomized Controlled Trial of the Effectiveness of Light Therapy and Fluoxetine in Patients With Winter Seasonal Affective Disorder. American Journal of Psychiatry. 163(5). 805–812. 168 indexed citations
9.
Michalak, Erin E., Greg Murray, Anthony Levitt, et al.. (2006). Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study. Psychological Medicine. 37(5). 727–736. 20 indexed citations
10.
Murray, Greg, Erin E. Michalak, Anthony Levitt, et al.. (2005). O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders. 90(2-3). 227–231. 24 indexed citations
11.
Murray, Greg, Erin E. Michalak, Anthony Levitt, et al.. (2005). Therapeutic Mechanism in Seasonal Affective Disorder: Do Fluoxetine and Light Operate Through Advancing Circadian Phase?. Chronobiology International. 22(5). 937–943. 37 indexed citations
12.
Michalak, Erin E., Edwin M. Tam, Kevin Solomons, et al.. (2004). Generic and health-related quality of life in patients with seasonal and nonseasonal depression. Psychiatry Research. 128(3). 245–251. 24 indexed citations
13.
Kutcher, Stan, Vivek Kusumakar, John C. LeBlanc, et al.. (2003). The characteristics of asymptomatic female adolescents at high risk for depression: the baseline assessment from a prospective 8-year study. Journal of Affective Disorders. 79(1-3). 177–185. 8 indexed citations
14.
Morehouse, Rachel, Vivek Kusumakar, Stan Kutcher, John C. LeBlanc, & Roseanne Armitage. (2002). Temporal coherence in ultradian sleep EEG rhythms in a never-depressed, high-risk cohort of female adolescents. Biological Psychiatry. 51(6). 446–456. 33 indexed citations
15.
Brownlee, Keith, Gerald M. Devins, Jonathan A.E. Fleming, et al.. (2002). Are there gender differences in the prescribing of hypnotic medications for insomnia?. Human Psychopharmacology Clinical and Experimental. 18(1). 69–73. 7 indexed citations
16.
Morehouse, Rachel, et al.. (1998). Depression and Short REM Latency in Subjects With Chronic Fatigue Syndrome. Psychosomatic Medicine. 60(3). 347–351. 9 indexed citations
17.
Broughton, Roger, Jonathan A.E. Fleming, C. F. George, et al.. (1997). Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology. 49(2). 444–451. 205 indexed citations
18.
Morehouse, Rachel, et al.. (1996). Adult Headbanging: Sleep Studies and Treatment. SLEEP. 19(4). 343–346. 41 indexed citations
19.
Morehouse, Rachel, et al.. (1995). Determination of Observer-rated Alpha Activity During Sleep. SLEEP. 3 indexed citations
20.
Morehouse, Rachel, et al.. (1995). Differential illness intrusiveness associated with sleep-promoting medications. European Psychiatry. 10(S3). 153s–159s. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich Hemmeter Breakdown of academic impact, for papers by Edda Pjrek Breakdown of academic impact, for papers by Ho‐Kyoung Yoon Breakdown of academic impact, for papers by D. Pringuey Breakdown of academic impact, for papers by Philippe Hubain Breakdown of academic impact, for papers by Andrés Magnússon Breakdown of academic impact, for papers by P. Schüssler Breakdown of academic impact, for papers by Euridice Campori Breakdown of academic impact, for papers by Norifumi Tsuno Breakdown of academic impact, for papers by N E Rosenthal
Rankless by CCL
2026